Methyl 2-(piperidin-4-yl)thiazole-4-carboxylate, 98%, 250mg

(R)-3-Phenylmorpholine hydrochloride, 97%, 250mg

2-(4-bromo-2-methylphenoxy)-N-1-naphthylacetamide, 95.0%, 1g

6-Methoxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, 98%, 1g

2-Bromo-4-methylbenzotrifluoride, 95.0%, 25g

2-CHLORO-4-((2,5-DIMETHYL-1-(4-(TRIFLUOROMETHOXY)PHENYL)-1H-IMIDAZOL-4-YL)ETHYNYL)PYRIDINE, 95%, 50mg

Ethylenediamine tetraacetic acid, min. 99%, 250 g, plastic packaging.

Hexyl Methanesulfonate>96.0%(GC)25g

Dimethyl 2-hydroxy-2,3-dihydrobenzofuran-4,6-dicarboxylate, 97%, 1g

2-((4-Bromophenyl)amino)-4-methyl-1,3-thiazole-5-carboxylic acid, 95%, 2g

3-Bromoquinolin-2-amine, 95.0%, 5g

2-tert-Butyloxycarbonylaminomethyl-5-methyl-[1,3,4]oxadiazole, 95.0%, 1g

5-tert-butyl 1-ethyl 5-azaspiro[2.4]heptane-1,5-dicarboxylate, 97.0%, 100mg